Balancing benefit and risk in TSH management of DTC

被引：1
|
作者：
Verburg, Frederik A. [1 ]
Luster, Markus [1 ]
机构：
[1] Univ Hosp Marburg, Dept Nucl Med, Marburg, Germany
来源：
NATURE REVIEWS ENDOCRINOLOGY | 2018年 / 14卷 / 03期
关键词：
DIFFERENTIATED THYROID-CARCINOMA; THERAPY; CANCER; AXIS;
D O I：
10.1038/nrendo.2018.1
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
TSH-suppressive therapy and the increased risk of cardiovascular disease in patients with differentiated thyroid cancer (DTC) was previously reported. A recent study by Pajamaki and colleagues found that patients with DTC have a higher risk of atrial fibrillation but a lower all-cause cardiovascular death rate. This study offers insights into this effect.
引用
收藏
页码：136 / U81
页数：2
相关论文
共 50 条
  • [41] Balancing the benefit and risk of oral antiplatelet agents in coronary artery bypass surgery
    Cannon, CP
    Mehta, SR
    Aranki, SF
    ANNALS OF THORACIC SURGERY, 2005, 80 (02): : 768 - 779
  • [42] Balancing gastrointestinal benefit-risk in individuals who are prescribed NSAIDs for arthritis
    Bijlsma, Johannes W. J.
    RHEUMATOLOGY, 2010, 49 : ii1 - ii2
  • [43] Balancing risk and benefit of SARS-CoV-2 vaccines in children Comment
    Levin, Michael
    Whittaker, Elizabeth
    LANCET REGIONAL HEALTH-EUROPE, 2022, 18
  • [44] Practical guidance for using rivaroxaban in patients with atrial fibrillation: balancing benefit and risk
    Haas, Sylvia
    Bode, Christoph
    Norrving, Bo
    Turpie, Alexander G. G.
    VASCULAR HEALTH AND RISK MANAGEMENT, 2014, 10 : 101 - 114
  • [45] BALANCING RISK AND BENEFIT IN HEAVY DRINKERS TREATED WITH TOPIRAMATE: IMPLICATIONS FOR PERSONALIZED CARE
    Kranzler, H. R.
    Feinn, R.
    Curtis, B.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2016, 40 : 164A - 164A
  • [46] Balancing benefit and risk from the patient's perspective: the comparative effectiveness table
    Kattan, Michael
    MULTIPLE SCLEROSIS JOURNAL, 2010, 16 (08) : 999 - 999
  • [47] BALANCING RISK AND BENEFIT: DEEP VENOUS THROMBOSIS SURVEILLANCE IN LUNG TRANSPLANT RECIPIENTS
    Jones, Lara
    Gelfond, Jonathan
    Keyt, Holly L.
    CHEST, 2024, 166 (04) : 6315A - 6315A
  • [48] Agreement in Balancing Benefit and Risk of New Drugs Between Patients, Doctors and Regulators
    Arnardottir, A. H.
    Krabbe, P. F.
    Dolu, I.
    De Graeff, P. A.
    Straus, S. M.
    Haaijer-Ruskamp, F. M.
    Denig, P.
    Mol, P. G. M.
    DRUG SAFETY, 2012, 35 (10) : 912 - 913
  • [49] Balancing Risk and Benefit in Heavy Drinkers Treated With Topiramate: Implications for Personalized Care
    Feinn, Richard
    Curtis, Brenda
    Kranzler, Henry R.
    JOURNAL OF CLINICAL PSYCHIATRY, 2016, 77 (03) : E278 - E282
  • [50] BALANCING BENEFIT VERSUS RISK IN THE CONTROL OF CONSUMER ITEMS CONTAINING RADIOACTIVE MATERIAL
    BRODSKY, A
    AMERICAN JOURNAL OF PUBLIC HEALTH AND THE NATIONS HEALTH, 1965, 55 (12): : 1971 - 1992
12345